Solcovagin solution for topical use

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate

Available from:

Legacy Pharmaceuticals Switzerland GmbH

ATC code:

առկա չէ (G02CX)

INN (International Name):

nitric acid 70%, glacial acetic acid, oxalic acid dihydrate, zinc nitrate hexahydrate

Dosage:

537mg/ml+ 20,4mg/ml+ 58,6mg/ml+ 6mg/ml

Pharmaceutical form:

solution for topical use

Units in package:

(2) glass vial 0,5ml

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2020-03-10

Summary of Product characteristics

1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Solcovagin
®
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:
1ml of the solution contains:
Nitric acid 70% 537.0 mg
Glacial acetic acid 20.4 mg
Oxalic acid dihydrate 58.6 mg
Zinc nitrate hexahydrate 6.0 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for topical use.
Clear, colorless solution.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTICINDICATIONS
Benign external trauma of cervix uteri, such as:

cervix uteri ectopia (ectropium, erythroplasia, pseudo-erosion).

transformations,

ovulaNabothi (afterincision),

cervical polyps (without endometrium pathology),

post-operation granuloma (after hysterectomy) of the cervix uteri.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Solcovagin
®
solution is designed for topical use only. by application to the
cervix uteri. The
medication should only be administered by a specialist(with the help
of colposcope).Treat the
damaged area, avoiding contact with the external genitals.

Mucus from the cervix uteri should be removed with a cotton swab. The
cervix uteri
should be wiped with 3% acetic acid solution, as a result of which the
level of trauma become
clearly visible.

Lightly treat the damaged area using a cotton stick moistened with
Solcovagin
®
solution.

After 1-2 minutes, treat the damaged area again using a new stick
moistened with
Solcovagin
®
solution. It is proven that such double application of the medication
is sufficient.

After this procedure the patient may go home. No special instructions
or limitations
concerning bathing, swimming or sexual activity are required.
2
SUMMARY OF PRODUCT CHARACTERISTICS

A control inspection and repeat procedure: 1
st
inspection –in 10 days after the procedure;
2
nd
inspection –in 14 days after 1
st
procedure; 3
rd
inspection – in 14 days after 2
nd
procedure. If the
damage has not completely cicatrized, Solcovagin
®
solution should be repeatedly applied twice
and the patient retur